These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1847764)

  • 21. Effects of an active substance isolated from the roots of Angelica shkiokiana on leukotriene and monohydroxyeicosatetreaenoic acid biosyntheses in human polymorphonuclear leukocytes.
    Kimura Y; Okuda H; Baba K; Kozawa M; Arichi S
    Planta Med; 1987 Dec; 53(6):521-5. PubMed ID: 2832866
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of thalidomide on arachidonic acid metabolism in human polymorphonuclear leukocytes and platelets.
    Maurice PD; Barkley AS; Allen BR
    Br J Dermatol; 1986 Dec; 115(6):677-80. PubMed ID: 3026430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury.
    Xu JA; Hsu CY; Liu TH; Hogan EL; Perot PL; Tai HH
    J Neurochem; 1990 Sep; 55(3):907-12. PubMed ID: 2166776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for generation of leukotriene B4 in human polymorphonuclear leukocytes treated with linoleylanilide.
    Garcia Gil M; Traver J; Suarez C; Marin Cao D; Mato JM
    Biochem Pharmacol; 1984 Oct; 33(20):3303-6. PubMed ID: 6091673
    [No Abstract]   [Full Text] [Related]  

  • 25. The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.
    Maurice PD; Camp RD; Allen BR
    Prostaglandins; 1987 Jun; 33(6):807-18. PubMed ID: 2823314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid.
    Ramesha CS; Pickett WC
    J Biol Chem; 1986 Jun; 261(17):7592-5. PubMed ID: 3011789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
    Lam BK; Yang CY; Wong PY
    Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inability of aflatoxin B1 to stimulate arachidonic acid metabolism in human polymorphonuclear and mononuclear leukocytes.
    Geissler FT; Henderson WR
    Carcinogenesis; 1988 Jul; 9(7):1135-8. PubMed ID: 2838195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of novel hydroxylated eicosatetraenoic acids in preparations of human polymorphonuclear leukocytes.
    Lindgren JA; Hansson G; Samuelsson B
    FEBS Lett; 1981 Jun; 128(2):329-35. PubMed ID: 6266876
    [No Abstract]   [Full Text] [Related]  

  • 30. Multiple effects of a new anti-inflammatory agent, timegadine, on arachidonic acid release and metabolism in neutrophils and platelets.
    Ahnfelt-Rønne I; Arrigoni-Martelli E
    Biochem Pharmacol; 1982 Aug; 31(16):2619-24. PubMed ID: 6291540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P-450LTB and inactivation of leukotriene B4.
    Soberman RJ
    Methods Enzymol; 1990; 187():319-24. PubMed ID: 2172735
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of 5-lipoxygenase activity in human polymorphonuclear leukocytes using high-performance liquid chromatography.
    McColl SR; Betts WH; Murphy GA; Cleland LG
    J Chromatogr; 1986 Jun; 378(2):444-9. PubMed ID: 3016012
    [No Abstract]   [Full Text] [Related]  

  • 33. Reactive oxygen species released by human blood neutrophils piroxicam-treated healthy subjects.
    Damon M; Chavis C; Le Doucen C; Blotman F; Crastes de Paulet A
    Adv Exp Med Biol; 1990; 264():265-9. PubMed ID: 2173873
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.
    Camp RD; Woollard PM; Mallet AI; Fincham NJ; Ford-Hutchinson AW; Bray MA
    Prostaglandins; 1982 May; 23(5):631-41. PubMed ID: 6289379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of leukotriene B4 by polymorphonuclear leukocytes during phagocytosis of Staphylococcus aureus.
    Henricks PA; van der Tol M; Verhoef J
    Agents Actions; 1986 Jan; 17(3-4):388-9. PubMed ID: 3008533
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions between prostaglandins and leukotrienes.
    Kuehl FA; Dougherty HW; Ham EA
    Biochem Pharmacol; 1984 Jan; 33(1):1-5. PubMed ID: 6322789
    [No Abstract]   [Full Text] [Related]  

  • 37. A previously unidentified leukotriene produced by human polymorphonuclear leukocytes.
    Jubiz W; Nolan G
    Biochem Biophys Res Commun; 1984 Apr; 120(2):548-52. PubMed ID: 6329173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients.
    Solá J; Vila L; Puig L; de Moragas JM
    Arch Dermatol Res; 1991; 283(2):77-80. PubMed ID: 2069415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonic acid metabolism in polymorphonuclear leukocytes from patients with chronic granulomatous disease.
    Smith DM; Walsh CE; Dechatelet LR; Waite M
    Infect Immun; 1983 Jun; 40(3):1230-3. PubMed ID: 6406364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of biological properties of synthetic and biological leukotriene B3.
    Evans J; Zamboni R; Nathaniel D; Leveillé C; Ford-Hutchinson AW
    Prostaglandins; 1985 Dec; 30(6):981-8. PubMed ID: 3003815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.